Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.4 replaces the previous revision (v3.5.3) on the page, signaling a backend platform update. It does not modify study data or other user-facing content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedUpdated the displayed revision/version number on the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision labeled v3.5.2 was added, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision history shows the addition of site revision v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.4.3 is added, replacing the previous v3.4.2. No substantive data or public content changes are indicated.SummaryDifference0.1%

- Check108 days agoChange DetectedA new revision entry (v3.4.2) was added, and older notices including a funding-status message and Revision: v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.